Atlas Trials

Exercise Treatment With Standard Therapy for Metastatic Breast Cancer

Clinical trial NCT03988595 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03988595
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Hormone Receptor Positive Metastatic Breast Cancer
Start date
2019-06-12
Primary completion
2026-08-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.